#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Factor IX deficiency Anal cancer Thrombotic thrombocytopenic purpura Chronic lymphocytic leukaemia refractory Crohn's disease Erythema Haemophilia B with anti factor IX Keratosis follicular Hyperinsulinism Dedifferentiated liposarcoma Hepatic angiosarcoma Primary biliary cholangitis Haemophilia A without inhibitors Immune-mediated enterocolitis Fms-like tyrosine kinase 3 positive More trials…

    Learn about Rare Diseases

    Acute respiratory distress syndrome – Life with Disease Tuberous sclerosis complex Tuberous sclerosis complex – Basic Information Angiosarcoma – Treatment Breast angiosarcoma – Treatment Fragile X syndrome – Basic Information Antisynthetase syndrome – Diagnostics Indolent systemic mastocytosis – Basic Information Tuberous sclerosis complex – Treatment Mantle cell lymphoma stage IV – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betula Verrucosa Pollen Arbaclofen Trastuzumab Etelcalcetide PRT3789 Mps-216 Eptacog Beta (Activated) Bupropion Hydrochloride Dexamethasone Acetate Cenerimod CLESROVIMAB 18F-Psma-1007 Serine Apremilast XMAB942 Dolutegravir Sodium Atacicept Nalbuphine Hydrochloride NIZUBAGLUSTAT Ptc518 More therapies…

    Learn about Your Condition

    Infectious pleural effusion Autoimmune haemolytic anaemia Liver transplant rejection Malformation venous Alveolar proteinosis Pancreatitis chronic Progressive supranuclear palsy Oesophageal carcinoma Hypochondroplasia Genitourinary tract neoplasm Relapsing multiple sclerosis Colorectal adenocarcinoma Angiopathy Epstein-Barr virus infection Krabbe's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Melatonin and Low-Dose Quetiapine for Patients with Psychiatric Disorders and Insomnia

    Recruiting

    4 1 1
    Investigated Diseases:
    • Insomnia
    Investigated Drugs:
    • Melatonin
    • Quetiapine
    Denmark

  • Study on Capsaicin Patch for Treating Chronic Neuropathic Pain in Children Aged 12-17

    Recruiting

    3 1 1
    Investigated Drugs:
    • Tramadol
    • Capsaicin
    France

  • Study on the Effects of Annual vs. Semi-Annual Ocrelizumab Infusions in Patients with Active Multiple Sclerosis After 2 Years of Initial Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    France

  • Study on the Safety and Effectiveness of Atogepant for Preventing Episodic Migraine in Children and Teens Aged 6 to 17

    Recruiting

    3 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    Belgium Denmark France Hungary Italy The Netherlands +4

  • Study on the Effectiveness of Ceftriaxone and Metronidazole Combination for Patients with Hurley Stage 2 Hidradenitis Suppurativa

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Lymecycline
    • Moxifloxacin
    • Ceftriaxone
    France

  • Study on Atopic Dermatitis Treatment with Baricitinib, Tralokinumab, Abrocitinib, Upadacitinib, and Dupilumab for Patients Needing Second-Line Systemic Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Tralokinumab
    • Baricitinib
    • Dupilumab
    Spain
Previous Page
1 … 598 599 600 601 602 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!